<?xml version="1.0" encoding="UTF-8"?>
<p>D.J. Clauw has performed consulting for Pfizer, Tonix, Samumed, Lilly, and Aptinyx, and has received research funding from Aptinyx. S.P. Cohen is supported by a grant from the U.S. Dept. of Defense, Uniformed Services University, Department of Physical Medicine &amp; Rehabilitation, Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) (HU00011920011). The remaining authors have no conflicts of interest to declare.</p>
